2023 - Research.com Biology and Biochemistry in United Kingdom Leader Award
2022 - Research.com Best Female Scientist Award
Her primary areas of investigation include Cell biology, Apoptosis, Biochemistry, Programmed cell death and Cancer research. Her Cell biology research includes themes of Ubiquitin, Cell growth, Cancer cell, Mdm2 and Nuclear protein. Her Cancer research extends to the thematically linked field of Apoptosis.
The Ubiquitin ligase, Serine, Cell survival and Flux research she does as part of her general Biochemistry study is frequently linked to other disciplines of science, such as Key issues, therefore creating a link between diverse domains of science. Her Programmed cell death study integrates concerns from other disciplines, such as Autophagy, Cell, Cytochrome c and Puma. Karen H. Vousden combines subjects such as Carcinogenesis, Tumor Protein p73, Transcription factor, Regulation of gene expression and p14arf with her study of Cancer research.
Karen H. Vousden mainly focuses on Cell biology, Cancer research, Mdm2, Apoptosis and Biochemistry. Her Cell biology research is multidisciplinary, incorporating perspectives in Molecular biology, Mutant, Programmed cell death and Cell growth. Karen H. Vousden has researched Mutant in several fields, including Mutation, Integrin and Plasma protein binding.
Her study looks at the intersection of Cancer research and topics like Carcinogenesis with Oncogene. Her research in Mdm2 intersects with topics in Proto-Oncogene Proteins c-mdm2, Ubiquitin, Ubiquitin ligase and DNA damage. Karen H. Vousden has included themes like Suppressor and Gene in her Function study.
Karen H. Vousden focuses on Cell biology, Cancer research, Mdm2, Programmed cell death and Cancer cell. Her research integrates issues of Glutamine, Mutant and In vivo in her study of Cell biology. The various areas that she examines in her Cancer research study include Carcinogenesis, KRAS, Pancreatic cancer and Immune system.
To a larger extent, Karen H. Vousden studies Apoptosis with the aim of understanding Programmed cell death. Her Apoptosis study integrates concerns from other disciplines, such as Neurodegeneration and Cell growth. Her work deals with themes such as Amino acid, Cell, Cell culture, Suppressor and Function, which intersect with Cancer cell.
Her primary areas of study are Cell biology, Cancer research, Cancer cell, Programmed cell death and Extracellular matrix. In her research, Karen H. Vousden undertakes multidisciplinary study on Cell biology and Diacylglycerol kinase. Her studies in Cancer research integrate themes in fields like Cell culture, Pancreatic cancer, Adenoma, KRAS and Normal tissue.
The study incorporates disciplines such as Mutation, Suppressor, Myeloid, Immune system and Function in addition to Cancer cell. Her Programmed cell death study combines topics from a wide range of disciplines, such as Cell, Diabetes mellitus, Cytosol, Disease and Metabolism. Her Extracellular matrix research incorporates elements of Microvesicles, Integrin, Mutant and Endosome.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Regulation of p53 stability by Mdm2
Michael H. G. Kubbutat;Stephen N. Jones;Karen H. Vousden.
Nature (1997)
Live or let die: the cell's response to p53
Karen H. Vousden;Xin Lu.
Nature Reviews Cancer (2002)
Proliferation, cell cycle and apoptosis in cancer
Gerard I. Evan;Karen H. Vousden.
Nature (2001)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden;Carol Prives.
Cell (2009)
PUMA, a novel proapoptotic gene, is induced by p53.
Katsunori Nakano;Karen H Vousden.
Molecular Cell (2001)
p53 in health and disease.
Karen H. Vousden;David P. Lane.
Nature Reviews Molecular Cell Biology (2007)
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Karim Bensaad;Atsushi Tsuruta;Mary A. Selak;M. Nieves Calvo Vidal.
Cell (2006)
The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2
Francesca J. Stott;Stewart Bates;Marion C. James;Beth B. McConnell.
The EMBO Journal (1998)
p53 mutations in cancer
Patricia A. J. Muller;Karen H. Vousden.
Nature Cell Biology (2013)
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Shengyun Fang;Jane P. Jensen;Robert L. Ludwig;Karen H. Vousden.
Journal of Biological Chemistry (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Glasgow
University of Glasgow
University of Rome Tor Vergata
University of Glasgow
Technion – Israel Institute of Technology
Weizmann Institute of Science
University of Glasgow
Cornell University
Cancer Research UK London Research Institute
University of Burgundy
Nanyang Technological University
Johannes Kepler University of Linz
Shandong Normal University
University of Würzburg
Shandong University
Boyce Thompson Institute
University of Rochester
Université Paris Cité
University of Virginia
University of Minnesota
Woods Hole Oceanographic Institution
Forschungszentrum Jülich
Pennsylvania State University
Oregon Research Institute
Catholic University of the Sacred Heart
Université Paris Cité